Simpson Curran bought RGNX
January 6, 2026 · Form 4 insider transaction
Simpson Curran bought 144,864 shares of REGENXBIO Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
144,864
Price
$0.00
Total value
N/A
InsiderSimpson Curran
RoleOfficer, Director
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after342,467
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer.